Literature DB >> 338877

Management of neonates and children with male pseudohermaphroditism.

P K Donahoe, J D Crawford, W H Hendren.   

Abstract

Twenty-five patients with male pseudohermaphroditism were treated. Causes included (1) inadequate testosterone production, (2) incomplete conversion of testosterone to dihydrotestosterone, and (3) insufficient androgen-binding protein at the target cell. These various problems can be defined accurately today. These infants should be studied early to define which gender role is more appropriate. Change in gender assignment later can be disastrous. An individual raised in the female role, but with incomplete internal structures, can cope with life better than one raised in the male role but lacking a satisfactory phallus. In general, we believe most male pseudohermaphrodites should be raised as females, performing appropriate alterations at an early age.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338877     DOI: 10.1016/0022-3468(77)90617-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

Review 1.  Intersex disorder associated with ambiguous genitalia.

Authors:  M Rohatgi
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

2.  Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme.

Authors:  Pradeep S Tanwar; LiHua Zhang; Yoshihiro Tanaka; Makoto M Taketo; Patricia K Donahoe; Jose M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Perineal reconstruction in ambiguous genitalia infants raised as females.

Authors:  P K Donahoe; W H Hendren
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

4.  Managing disorder of sexual development surgically: A single center experience.

Authors:  Jatinder Kumar; Vikas Kumar; Vijaylakshmi Bhatia; Preeti Dabadghao; Samit Chaturvedi; Rakesh Kapoor; M S Ansari
Journal:  Indian J Urol       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.